Rallies Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-04-2024
- Paid Up Capital ₹ 0.10 M
as on 17-04-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
About Rallies Drugs
- CIN/LLPIN
U24232DL2008PTC176931
- Company No.
176931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2008
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rallies Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudarshan Thirani  | Director | 21-Apr-2008 | Current |
| Suresh Thirani | Director | 21-Apr-2008 | Current |
Financial Performance of Rallies Drugs.
Enhance accessibility to Rallies Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rallies Drugs?
In 2016, Rallies Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Growmax Medicare Private LimitedActive 16 years 9 monthsSudarshan Thirani and Suresh Thirani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rallies Drugs?
Unlock and access historical data on people associated with Rallies Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rallies Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rallies Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
